Serologic responses to the MVA-based JYNNEOS mpox vaccine in a cohort of participants from the District of Columbia (D.C.).
Griffin I, Berry I, Navarra T, Priyamvada L, Carson WC, Noiman A, Jackson DA, Waltenburg MA, Still W, Lujan L, Beverly J, Willut C, Lee M, Mangla A, Shelus V, Hutson CL, Townsend MB, Satheshkumar PS; CDC Monkeypox Laboratory Task Force Team, CDC Monkeypox DC PEP++ Field Team.
Griffin I, et al.
Vaccine. 2024 May 17:S0264-410X(24)00563-2. doi: 10.1016/j.vaccine.2024.05.017. Online ahead of print.
Vaccine. 2024.
PMID: 38762357